HIV patients whose antiretroviral therapy was initiated and managed by pharmacists achieved earlier viral suppression compared with those managed by a primary HIV clinician. More
FDA said that sitagliptin, saxagliptin, linagliptin, and alogliptin may cause joint pain, and their labels have been revised to include this risk. More
